Selenium Thyroid Meta-analysis: What the Evidence Says

Quick Answer

Selenium Thyroid Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are mixed biomedical and public-health sources, so conclusions should be framed as evidence-aware guidance rather than medical advice.

Key Takeaways

• This page is generated only from sources stored in the Migaku evidence knowledge base.
• Current evidence mix: 1 narrative review, 1 observational study.
• Claims should be interpreted with the source type, study design, population, and publication date in mind.
• This article is educational and does not replace care from a qualified clinician.

Evidence Map

What The Sources Report

• Emerging evidence suggests that alterations in gut microbial composition may contribute to the pathogenesis and progression of autoimmune diseases, both within the gastrointestinal tract and at distant sites. [Beyhan Yunus Emre (2026); evidence level 3]
• Beyond immune regulation, accumulating evidence indicates that the gut microbiota contributes to thyroid homeostasis by modulating the intestinal handling of key micronutrients. [Beyhan Yunus Emre (2026); evidence level 3]
• Selenium deficiency has been associated with an increased risk of autoimmune thyroid disorders, including HT. [Toraih Eman A. (2026); evidence level 3]
• In these patients, there may be a high risk of developing other autoimmune disorders, as evidence has been shown for rheumatoid arthritis, systemic lupus erythematosus, or celiac disease. [Toraih Eman A. (2026); evidence level 3]

How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

Practical Interpretation

For selenium thyroid meta-analysis, the current source set is useful for orientation, but it is not yet broad enough for strong claims. Use cautious language and keep conclusions close to the cited sources.

Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

References

• Beyhan Yunus Emre (2026). Gut Microbiota and Thyroid Diseases. DOI: 10.5152/eurasianjmed.2026.251232. PMCID: PMC13185599. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13185599/
• Toraih Eman A. (2026). Clinical Outcomes of Selenium Supplementation in Hashimoto's Thyroiditis Without Selenium Deficiency: A Large‐Scale Retrospective Cohort Study. DOI: 10.1002/edm2.70239. PMCID: PMC13184170. PMID: 42152509. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13184170/

Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.